Literature DB >> 4264575

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.

A P Kaplan, K F Austen.   

Abstract

The conversion of the plasminogen proactivator to plasminogen activator by activated Hageman factor or its fragments has been recognized as an essential step in the conversion of plasminogen to plasmin. The plasminogen proactivator has been completely separated from prekallikrein and pre-PTA, two other proenzyme substrates of activated Hageman factor or its fragments. Plasminogen proactivator, free of any contaminating proteins as assessed by disc gel electrophoresis or isoelectric focusing, revealed a single band with an isoelectric point of 8.9 corresponding in position to the Hageman factor activatable material eluted from replicate unstained gels. After conversion of plasminogen proactivator by Hageman factor fragments to the plasminogen activator, the active site of the plasminogen activator is not inhibited by C1INH and is thus readily distinguished from that of kallikrein or PTA. The plasminogen activator is susceptible to inactivation by DFP while the plasminogen proactivator is not, as has been the case for esterases having a serine in the active site. Its interaction with plasminogen is inhibited by epsilon-aminocaproic acid.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4264575      PMCID: PMC2139321          DOI: 10.1084/jem.136.6.1378

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS.

Authors:  L J KAGEN
Journal:  Br J Exp Pathol       Date:  1964-12

2.  Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.

Authors:  F B ABLONDI; J J HAGAN; M PHILIPS; E C DE RENZO
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

3.  Interaction of streptokinase and human plasminogen. V. Studies on the nature and mechanism of formation of the enzymatic site of the activator complex.

Authors:  F F Buck; B C Hummel; E C De Renzo
Journal:  J Biol Chem       Date:  1968-07-10       Impact factor: 5.157

4.  Interaction of streptokinase and human plasminogen. VI. Function of the streptokinase moiety in the activator complex.

Authors:  F F Buck; E Boggiano
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

5.  Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations.

Authors:  P Wallén; B Wiman
Journal:  Biochim Biophys Acta       Date:  1970-10-20

6.  Studies on the participation of Hageman factor in fibrinolysis.

Authors:  R P McDonagh; J H Ferguson
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31

7.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

8.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

9.  A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

10.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  33 in total

1.  Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.

Authors:  A S Weiss; J I Gallin; A P Kaplan
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  Partial purification and characterization of contact activation cofactor.

Authors:  S Schiffman; P Lee
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

Review 3.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

Review 4.  [The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].

Authors:  R E Zimmermann; J Lubinus
Journal:  Klin Wochenschr       Date:  1978-08-15

5.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Authors:  H L Meier; J V Pierce; R W Colman; A P Kaplan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

6.  Acute Babesia bigemina infection: changes in coagulation and kallikrein parameters.

Authors:  I G Wright; B V Goodger
Journal:  Z Parasitenkd       Date:  1977-08-25

7.  Association of factor XI and high molecular weight kininogen in human plasma.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

8.  A phagocytosis-enhancing factor in human plasma.

Authors:  I Gigli; B U Wintroub; E J Goetzl
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

9.  Acquired antibody to factor XI in a patient with congenital factor XI deficiency.

Authors:  D M Stern; H L Nossel; J Owen
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.

Authors:  A P Kaplan; E J Goetzl; K F Austen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.